Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
Conditions:   Cryptococcosis;   Lung Adenocarcinoma Intervention:   Diagnostic Test: A scoring system Sponsor:   Shanghai Pulmonary Hospital, Shanghai, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2020 Category: Research Source Type: clinical trials

Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
Conditions:   HIV Infections;   Tuberculosis;   Candidiasis, Esophageal;   Cryptococcosis;   Leishmaniasis;   Toxoplasmosis Intervention:   Other: CD4 cell count Sponsor:   Singh, Ranjan Kumar, M.D. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2019 Category: Research Source Type: clinical trials

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
SAN DIEGO– February 11, 2019– Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Product Development... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 11, 2019 Category: Pharmaceuticals Source Type: clinical trials

Vietnam Cryptococcal Retention in Care Study - Version 2.1
Conditions:   HIV/AIDS;   Cryptococcal Meningitis;   Opportunistic Infections, HIV Related;   Cryptococcosis;   Mycosis; Opportunistic;   Mycosis Fungoides Intervention:   Other: Preemptive high-dose Fluconazole Sponsors:   National Hospital for Tropical Diseases, Hanoi, Vietnam;   Centers for Disease Control and Prevention;   Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam Completed - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2017 Category: Research Source Type: clinical trials

Cryptococcal Antigen Screening Plus Sertraline
Conditions:   Cryptococcosis;   Cryptococcal Infections;   AIDS-Related Opportunistic Infections Interventions:   Drug: Sertraline;   Drug: Placebo Oral Tablet;   Drug: Fluconazole Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Infectious Diseases Institute, Uganda;   National Institute of Allergy and Infectious Diseases (NIAID);   Mbarara University of Science and Technology Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2016 Category: Research Source Type: clinical trials